Fundraising Fox
Beacontx
Founded 2023 · 96 employees on LinkedIn · 5 known investors
Find your way into Beacontx
Sign up to see every warm intro you have to Beacontx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Beacontx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Beacon Therapeutics develops gene therapies for patients with serious diseases that lack or have limited treatment options, including investigational products like laru-zova for genetic conditions.
Founders & leadership
DC
Daniel ChungChief Medical OfficerDaniel Chung is Chief Medical Officer at Beacon Therapeutics, which develops gene therapies for serious diseases. He brings clinical and medical leadership experience in biotechnology, with specific expertise in ocular gene therapy, translational research, clinical development, and inherited retinal diseases.
LB
Lance BaldoChief Executive OfficerLance Baldo is a physician and executive with experience in pharmaceutical lifecycle management, business strategy, and medical affairs. He is CEO of Beacon Therapeutics, a gene therapy company developing treatments for serious diseases with limited treatment options.
AS
Abraham ScariaChief Scientific OfficerAbraham Scaria is Chief Scientific Officer of Beacontx, a gene therapy company developing treatments for serious genetic and autoimmune diseases.
Investors · 5
Frequently asked questions
- What does Beacontx do?
- Beacon Therapeutics develops gene therapies for patients with serious diseases that lack or have limited treatment options, including investigational products like laru-zova for genetic conditions.
- Who are Beacontx's investors?
- Beacontx's investors include Advent Life Sciences, Forbion, Oxford Science Enterprises, Syncona, TCG Crossover.